Monday 20 July 2026

One To Watch

BlossomHill Therapeutics

A biotechnology company developing small molecule medicines for treating cancer and autoimmune diseases.

Company Overview

Want to Update your Company's Profile?


More BlossomHill Therapeutics news >


Today's issue

BMS expands NVIDIA tie-up with Vera Rubin AI factory
Pharmaceutical
BMS expands NVIDIA tie-up with Vera Rubin AI factory
20 July 2026
Pharmaceutical
Gates Medical Research Institute links up with SII on vaccines
20 July 2026
Biotechnology
Almirall seeks broader EU approval for Ebglyss in younger children with atopic dermatitis
20 July 2026
Biotechnology
Regenxbio prices expected $100M public offering
20 July 2026
Pharmaceutical
From persistence to precision: how Daiichi Sankyo is evolving its R&D strategy in oncology
20 July 2026
Biotechnology
4DMT reports two-year benefit for wet AMD gene therapy
20 July 2026
Biotechnology
Samsung Biologics to acquire PolyPeptide
20 July 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze